Literature DB >> 26355570

A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UK.

Raphaël Mourad1, François Chevennet, David T Dunn, Esther Fearnhill, Valerie Delpech, David Asboe, Olivier Gascuel, Stéphane Hue.   

Abstract

OBJECTIVE: Antiretroviral-naive HIV-positive individuals contribute to the transmission of drug-resistant viruses, compromising first-line therapy. Using phylogenetic inference, we quantified the proportion of transmitted drug-resistance originating from a treatment-naive source.
METHODS: Using a novel phylotype-based approach, 24 550 HIV-1 subtype B partial pol gene sequences from the UK HIV Drug Resistance database were analysed. Ongoing transmission of drug resistance amongst HIV-positive individuals was identified as phylotypes of at least three sequences with at least one shared drug resistance mutation, a maximum intra-clade genetic distance of 4.0% and a basal branch support at least 90%. The time of persistence of the transmission chains was estimated using a fast least-squares molecular clock inference approach.
RESULTS: Around 70% of transmitted drug-resistance had a treatment-naive source. The most commonly transmitted mutations were L90M in the protease gene and K103N, T215D and T215S in reverse transcriptase. Reversion to wild type occurred at a low frequency and drug-independent reservoirs of resistance have persisted for up to 13 years.
CONCLUSION: These results illustrate the impact of viral fitness on the establishment of resistance reservoirs and support the notion that earlier diagnoses and treatment of HIV infections are warranted for counteracting the spread of antiretroviral resistance. Phylotype-based phylogenetic inference is an attractive approach for the routine surveillance of transmitted drug resistance in HIV as well as in other pathogens for which genotypic resistance data are available.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26355570     DOI: 10.1097/QAD.0000000000000768

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  24 in total

1.  Transmission fitness of drug-resistant HIV revealed in a surveillance system transmission network.

Authors:  Joel O Wertheim; Alexandra M Oster; Jeffrey A Johnson; William M Switzer; Neeraja Saduvala; Angela L Hernandez; H Irene Hall; Walid Heneine
Journal:  Virus Evol       Date:  2017-04-19

Review 2.  Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation.

Authors:  Catherine Godfrey; Michael C Thigpen; Keith W Crawford; Patrick Jean-Phillippe; Deenan Pillay; Deborah Persaud; Daniel R Kuritzkes; Mark Wainberg; Elliot Raizes; Joseph Fitzgibbon
Journal:  J Infect Dis       Date:  2017-12-01       Impact factor: 5.226

Review 3.  The Role of Phylogenetics as a Tool to Predict the Spread of Resistance.

Authors:  Anna Zhukova; Teresa Cutino-Moguel; Olivier Gascuel; Deenan Pillay
Journal:  J Infect Dis       Date:  2017-12-01       Impact factor: 5.226

4.  Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.

Authors:  Aubin J Nanfack; Andrew D Redd; Jude S Bimela; Genesis Ncham; Emmanuel Achem; Andrew N Banin; Allison R Kirkpatrick; Stephen F Porcella; Lucy A Agyingi; Josephine Meli; Vittorio Colizzi; Arthur Nádas; Miroslaw K Gorny; Phillipe N Nyambi; Thomas C Quinn; Ralf Duerr
Journal:  J Clin Microbiol       Date:  2017-06-28       Impact factor: 5.948

5.  Prevalence and Evolution of Transmitted Human Immunodeficiency Virus Drug Resistance in Belgium Between 2013 and 2019.

Authors:  Virginie Mortier; Laurent Debaisieux; Géraldine Dessilly; Karolien Stoffels; Dolores Vaira; Ellen Vancutsem; Kristel Van Laethem; Fien Vanroye; Chris Verhofstede
Journal:  Open Forum Infect Dis       Date:  2022-04-12       Impact factor: 4.423

6.  Patterns of Transmitted Drug Resistance and Virological Response to First-line Antiretroviral Treatment Among Human Immunodeficiency Virus-Infected People Who Use Illicit Drugs in a Canadian Setting.

Authors:  M Eugenia Socías; Ekaterina Nosova; Thomas Kerr; Kanna Hayashi; P Richard Harrigan; Jeannie Shoveller; Julio Montaner; M-J Milloy
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

7.  Fast Dating Using Least-Squares Criteria and Algorithms.

Authors:  Thu-Hien To; Matthieu Jung; Samantha Lycett; Olivier Gascuel
Journal:  Syst Biol       Date:  2015-09-30       Impact factor: 15.683

Review 8.  HIV-1 drug resistance and resistance testing.

Authors:  Dana S Clutter; Michael R Jordan; Silvia Bertagnolio; Robert W Shafer
Journal:  Infect Genet Evol       Date:  2016-08-29       Impact factor: 3.342

9.  HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy.

Authors:  Santiago Avila-Ríos; Claudia García-Morales; Daniela Tapia-Trejo; Rita I Meza; Sandra M Nuñez; Leda Parham; Norma A Flores; Diana Valladares; Luisa M Pineda; Dixiana Flores; Roxana Motiño; Víctor Umanzor; Candy Carbajal; Wendy Murillo; Ivette Lorenzana; Elsa Y Palou; Gustavo Reyes-Terán
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

10.  Pretreatment integrase strand transfer inhibitor resistance in North Carolina from 2010-2016.

Authors:  Timothy W Menza; Rachael Billock; Erika Samoff; Joseph J Eron; Ann M Dennis
Journal:  AIDS       Date:  2017-10-23       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.